Medivis Wins FDA Clearance for Breakthrough Augmented Reality Surgical System

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Medivis announced today that its groundbreaking augmented reality (AR) technology platform for surgical applications, SurgicalAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration. The New York City based medical technology company will commence the immediate commercialization of the platform in the United States.

MedivisThe enterprise SurgicalAR platform integrates the latest advancements in augmented reality, artificial intelligence, and computer vision to advance surgical visualization, thereby decreasing surgical complications and improving patient outcomes — all while lowering costs to the healthcare system.

“Holographic visualization is the final frontier of surgical imaging and navigation,” said Dr. Osamah Choudhry, neurosurgeon & CEO of Medivis. “The surgical world continues to primarily rely on two-dimensional imaging technology to understand and operate on incredibly complex patient pathology. ”

“Medivis introduces advancements in holographic visualization and navigation to fundamentally advance surgical intervention, and revolutionize how surgeons safely operate on their patients,” said Dr. Christopher Morley, radiologist & President of Medivis. “Achieving this milestone accelerates our mission to improve surgical precision and safety by allowing surgeons to see the invisible.”

This announcement comes on the heels of significant company momentum, including strategic partnerships with Verizon and Microsoft. Earlier this year, the company came out of stealth with $2.3M in funding, led by Initialized Capital. The company also recently released their AnatomyX platform for AR medical training.

“Medical imaging for invasive surgical procedures has been waiting for a transformation like this for decades —and we knew from day one that Medivis would be the leader in this emerging space,” Eric Woersching, General Partner, Initialized Capital.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.